The findings were presented at the 17th Clinical Trials on Alzheimer's Disease (CTAD) conference. Metabolic and vascular ...
Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...
After some time, early symptomatic Alzheimer's disease begins with a small amount of memory loss and confusion that can be ...
"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...
Popular Diabetes and Weight-Loss Drug May Reduce Risk of Alzheimer's Disease Oct. 24, 2024 — Researchers have found that semaglutide may lower the risk of Alzheimer's disease in people with type ...
Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...
Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...
The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...
Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...
Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...
The National Institutes of Health reports that incidences of Alzheimer's disease and other dementia increased by roughly 148 ...
The Northeastern New York chapter of the Alzheimer's Association held it's 2024 Walk to End Alzheimer's at the Clark Sports ...